ATE177648T1 - Gezielte zerstörung neoplastischer zellen mit hilfe von retrovirusvektor-produzierenden packungszelllinien - Google Patents

Gezielte zerstörung neoplastischer zellen mit hilfe von retrovirusvektor-produzierenden packungszelllinien

Info

Publication number
ATE177648T1
ATE177648T1 AT91308438T AT91308438T ATE177648T1 AT E177648 T1 ATE177648 T1 AT E177648T1 AT 91308438 T AT91308438 T AT 91308438T AT 91308438 T AT91308438 T AT 91308438T AT E177648 T1 ATE177648 T1 AT E177648T1
Authority
AT
Austria
Prior art keywords
neoplastic cells
cell lines
packaging cell
retrovirus vector
producing packaging
Prior art date
Application number
AT91308438T
Other languages
English (en)
Inventor
Robert L Martuza
Xandra O Breakfield
Original Assignee
Gen Hospital Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27078482&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE177648(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Gen Hospital Corp filed Critical Gen Hospital Corp
Application granted granted Critical
Publication of ATE177648T1 publication Critical patent/ATE177648T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/45—Transferases (2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6901—Conjugates being cells, cell fragments, viruses, ghosts, red blood cells or viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
    • C12N2710/16622—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/13011—Gammaretrovirus, e.g. murine leukeamia virus
    • C12N2740/13041—Use of virus, viral particle or viral elements as a vector
    • C12N2740/13043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Plant Pathology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physics & Mathematics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT91308438T 1990-09-14 1991-09-16 Gezielte zerstörung neoplastischer zellen mit hilfe von retrovirusvektor-produzierenden packungszelllinien ATE177648T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US58205590A 1990-09-14 1990-09-14
US74665591A 1991-08-16 1991-08-16

Publications (1)

Publication Number Publication Date
ATE177648T1 true ATE177648T1 (de) 1999-04-15

Family

ID=27078482

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91308438T ATE177648T1 (de) 1990-09-14 1991-09-16 Gezielte zerstörung neoplastischer zellen mit hilfe von retrovirusvektor-produzierenden packungszelllinien

Country Status (5)

Country Link
EP (1) EP0476953B1 (de)
JP (1) JPH05246895A (de)
AT (1) ATE177648T1 (de)
CA (1) CA2051288C (de)
DE (1) DE69130996T2 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5997859A (en) * 1988-03-21 1999-12-07 Chiron Corporation Method for treating a metastatic carcinoma using a conditionally lethal gene
US5716826A (en) 1988-03-21 1998-02-10 Chiron Viagene, Inc. Recombinant retroviruses
US6133029A (en) 1988-03-21 2000-10-17 Chiron Corporation Replication defective viral vectors for infecting human cells
US6569679B1 (en) 1988-03-21 2003-05-27 Chiron Corporation Producer cell that generates adenoviral vectors encoding a cytokine and a conditionally lethal gene
US5662896A (en) 1988-03-21 1997-09-02 Chiron Viagene, Inc. Compositions and methods for cancer immunotherapy
DE69313443T2 (de) * 1992-05-01 1998-03-19 Us Health Warte-effekt bei tumorzerstörender therapie
GB9305759D0 (en) * 1993-03-19 1993-05-05 Medical Research Council And T Hiv therapy method and agents
JPH09505561A (ja) * 1993-10-01 1997-06-03 アメリカ合衆国 神経系の遺伝子治療
CA2173495A1 (en) * 1993-10-06 1995-04-13 Kenneth W. Culver Treatment of tumors by genetic transformation of tumor cells with genes encoding negative selective markers and cytokines
KR960703172A (ko) 1993-11-18 1996-06-19 스티븐 제이. 멘토 조건적으로 치사적인 유전자를 활용하기 위한 조성물 및 방법(Compositions and methods for utilizing conditionally lethal genes)
EP0758387B1 (de) * 1994-05-02 2001-12-19 University of Washington Thymidin-kinase-mutanten
US6451571B1 (en) 1994-05-02 2002-09-17 University Of Washington Thymidine kinase mutants
US6638762B1 (en) 1994-11-28 2003-10-28 Genetic Therapy, Inc. Tissue-vectors specific replication and gene expression
US5998205A (en) 1994-11-28 1999-12-07 Genetic Therapy, Inc. Vectors for tissue-specific replication
WO1996022112A1 (en) 1995-01-17 1996-07-25 Genetic Therapy, Inc. Delivery of therapeutic agents by gene therapy
ATE309000T1 (de) 1995-06-27 2005-11-15 Bavarian Nordic As Verkapselte zellen die virenpartikeln produzieren
US6602499B1 (en) 1998-04-30 2003-08-05 The General Hospital Corporation Combination viral-based and gene-based therapy of tumors
US7575924B2 (en) 2000-11-13 2009-08-18 Research Development Foundation Methods and compositions relating to improved lentiviral vectors and their applications
ATE527347T1 (de) 2001-08-02 2011-10-15 Inst Clayton De La Rech Verfahren und zusammensetzungen im zusammenhang mit verbesserten lentivirusvektor- produktionssystemen
CA2462628C (en) * 2001-10-02 2019-08-20 Institut Clayton De La Recherche Restricted expression lentiviral vectors

Also Published As

Publication number Publication date
DE69130996D1 (de) 1999-04-22
EP0476953A3 (en) 1992-12-16
DE69130996T2 (de) 1999-07-29
CA2051288C (en) 2002-02-05
CA2051288A1 (en) 1992-03-15
EP0476953A2 (de) 1992-03-25
EP0476953B1 (de) 1999-03-17
JPH05246895A (ja) 1993-09-24

Similar Documents

Publication Publication Date Title
DE69130996D1 (de) Gezielte Zerstörung neoplastischer Zellen mit Hilfe von Retrovirusvektor-produzierenden Packungszelllinien
FI890406A0 (fi) Polymera material.
DK0568537T3 (da) Genetisk modificering af endotelceller
DK158659C (da) 2,4,6-triiod-isophthalsyrederivater, deres fremstilling og roentgenkontrastmidler indeholdende disse.
TR28980A (tr) Hidrofilik polimer bilesimi ve bunu ihtiva eden ürün.
ES2023417B3 (es) Procedimiento para polimerizar una o mas 1-olefinas en fase gaseosa en presencia de material inorganico pulverulento.
FI862380A7 (fi) Lasersädettä kestävä materiaali.
ES278850Y (es) Expendedor de material laminar.
IT8420245A0 (it) Fune di trasporto ad organi raschianti in materia plastica.
DE3789313D1 (de) Laser-aufschweissmaterial und dessen verwendung zum laser-aufschweissen.
DE3579045D1 (de) Lagermaterial und dessen herstellungsverfahren.
FI875467A7 (fi) DNA-molekyylit, jotka ovat hyödyllisiä kasviensuojelussa.
FI885716L (fi) Foerfarande och anordning foer sterilisering av innehaollet i containers tillverkade av dielektriskt material.
FI880582A0 (fi) Paperinvalmistuksessa käytettävät uudet valmisteet
IT8022385A0 (it) Agenti per la gelificazione di fluoroelastomeri e prodotti con essi ottenuti.
IT1188214B (it) Stabilizzante alla luce per polimeri,particolarmente per polipropilene,polietilene,polistirolo e per polimeri contenenti cloro
DE3676901D1 (de) Wickelachse zum anbringen von umhuellungsmaterial.
TR20254A (tr) 1,3,4-tiyadiyazol-2-karboksilik asit tuerevleri,bu bilesim imaline mahsus usuller ve bunlari ihtiva eden fungisit ve nemasit maddeler
DK157618C (da) Gummiagtigt stof, baseret paa pektin og gelatine, til brug i konfekturevarer og konfekturevare indeholdende samme
DE3688883D1 (de) Strukturmaterial und dessen herstellung.
DE58902502D1 (de) 2,6-polyalkylpiperidinsubstituierte benzimidazol-2-carbonsaeureanilide und deren verwendung zum stabilisieren von organischem material.
ATA68181A (de) Vorrichtung zum ein- oder beidseitigen besaeumen von brettern, balken u. dgl.
FI940822A0 (fi) Foerfarande foer mikrobiologisk rening av material, som innehaoller skadliga aemnen
ATE219521T1 (de) Toxisches protein exprimierende viren und produktionszellinien
DE3481049D1 (de) Staubfreier behaelter und dessen herstellung.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee
RZN Patent revoked